Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations now includes New York; HHS Vulnerability Disclosure and New York Locations were removed. Page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:22:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed an administrative notice about government funding and NIH operating status from the study page. This is an operational change and does not affect the study details, eligibility criteria, or results planning.
    Difference
    0.4%
    Check dated 2025-11-17T19:13:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Results have been posted for the study; the results section and related dates (e.g., Results First Posted) have been added or updated. Primary and secondary outcome measures are now presented.
    Difference
    0.5%
    Check dated 2025-11-03T13:16:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government funding/operating-status notice for the NIH Clinical Center; removed reference to v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:13:36.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.5%
    Check dated 2025-09-28T23:35:50.000Z thumbnail image

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.